CORRECTION article

Front. Immunol., 24 November 2022

Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1098003

Corrigendum: Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese

  • 1. Department of Nephrology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • 2. NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China

  • 3. Division of Nephrology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Article metrics

View details

980

Views

672

Downloads

In the published article, there was an error regarding the affiliations for all authors. As well as having affiliation 1, they should also have “2NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China”.

The author Ming Li should also have “3Division of Nephrology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

IgA nephropathy, complement factor B, case-control study, alternative pathway, polymorphism

Citation

Shi D-C, Feng S-Z, Zhong Z, Cai L, Wang M, Fu D-Y, Yu X-Q and Li M (2022) Corrigendum: Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese. Front. Immunol. 13:1098003. doi: 10.3389/fimmu.2022.1098003

Received

14 November 2022

Accepted

15 November 2022

Published

24 November 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Ming Li,

†These authors have contributed equally to this work and share first authorship

This article was submitted to Autoimmune and Autoinflammatory Disorders: Autoimmune Disorders, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics